Dolosys Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 6

Dolosys General Information

Description

Developer of a pain monitoring and stimulating device designed to assist in the objective measurement of pain and pain control. The company's pain monitoring device offers to optimize pain therapy for sedated intensive care patients and patients with chronic pain, enabling healthcare organizations to provide better pain management alternatives to their patients.

Contact Information

Website
www.dolosys.de
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Primary Office
  • Wöhlertstrasse 8
  • 10115 Berlin
  • Germany
+49 030 00000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dolosys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Generating Revenue
3. Grant 28-Aug-2014 000 Completed Generating Revenue
2. Early Stage VC 15-May-2013 Completed Generating Revenue
1. Grant 18-Jun-2012 $5.02K Completed Startup
To view Dolosys’s complete valuation and funding history, request access »

Dolosys Executive Team (3)

Name Title Board Seat Contact Info
Jan Baars Co-Founder & Managing Director
Alf Baars Co-Founder
Jürgen Schlossbauer Co-Founder
To view Dolosys’s complete executive team members history, request access »

Dolosys Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Berliner Sparkasse Investment Bank 000 0000 000000 0
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
M2F Investment Venture Capital Minority 000 0000 000000 0
Exist Federal Ministry of Economics and Energy Government 000 0000 000000 0
Federal Ministry for Economic Affairs and Energy Limited Partner 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »